Although endovascular therapy of femoropopliteal lesions with nitinol bare metal stents improves the relatively low primary patency rates achieved with balloon angioplasty, up to 37% of BMS-treated femoropopliteal lesions develop in-stent...
Although endovascular therapy of femoropopliteal lesions with nitinol bare metal stents improves the relatively low primary patency rates achieved with balloon angioplasty, up to 37% of BMS-treated femoropopliteal lesions develop in-stent...
Although endovascular therapy of...